NCT00351130View on ClinicalTrials.gov

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

79

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Hypertension
Interventions
DRUG

valsartan

DRUG

amlodipine

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00351130 - Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy | Biotech Hunter | Biotech Hunter